| 0 |
AMYLOID ARTHROPATHY |
15 |
0.2143 |
| 1 |
DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL |
2 |
0.0741 |
| 2 |
ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE |
5 |
0.0549 |
| 3 |
BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT |
4 |
0.0392 |
| 4 |
PRODUCT ADMINISTRATION ISSUE |
7 |
0.0335 |
| 5 |
DEPRESCRIBING ERROR |
2 |
0.0308 |
| 6 |
MYELOBLAST COUNT INCREASED |
2 |
0.0260 |
| 7 |
BILIRUBIN CONJUGATED ABNORMAL |
2 |
0.0180 |
| 8 |
OVERLAP SYNDROME |
9 |
0.0129 |
| 9 |
INFECTIVE GLOSSITIS |
2 |
0.0128 |
| 10 |
PITYRIASIS RUBRA PILARIS |
3 |
0.0126 |
| 11 |
HYDROTHORAX |
10 |
0.0120 |
| 12 |
ANASTOMOTIC LEAK |
6 |
0.0086 |
| 13 |
ICHTHYOSIS |
2 |
0.0079 |
| 14 |
DUMPING SYNDROME |
2 |
0.0076 |
| 15 |
UTERINE MASS |
3 |
0.0073 |
| 16 |
NAIL DYSTROPHY |
4 |
0.0071 |
| 17 |
VASCULITIC RASH |
5 |
0.0065 |
| 18 |
C-REACTIVE PROTEIN |
6 |
0.0065 |
| 19 |
PULMONARY PAIN |
18 |
0.0062 |
| 20 |
ANAL ULCER |
5 |
0.0061 |
| 21 |
BILIARY CIRRHOSIS PRIMARY |
2 |
0.0058 |
| 22 |
HEPATITIS B CORE ANTIBODY POSITIVE |
2 |
0.0053 |
| 23 |
NEOPLASM SKIN |
8 |
0.0051 |
| 24 |
LIBIDO INCREASED |
10 |
0.0049 |
| 25 |
OTITIS MEDIA CHRONIC |
2 |
0.0048 |
| 26 |
LUPUS VULGARIS |
6 |
0.0048 |
| 27 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
5 |
0.0047 |
| 28 |
OESOPHAGEAL DILATATION |
2 |
0.0045 |
| 29 |
HOMELESS |
2 |
0.0045 |
| 30 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
9 |
0.0045 |
| 31 |
IMMUNE-MEDIATED HYPOPHYSITIS |
2 |
0.0044 |
| 32 |
MECHANICAL URTICARIA |
2 |
0.0043 |
| 33 |
ECZEMA ASTEATOTIC |
2 |
0.0042 |
| 34 |
CALCULUS URETERIC |
3 |
0.0041 |
| 35 |
PALMOPLANTAR KERATODERMA |
3 |
0.0041 |
| 36 |
ELECTROLYTE DEPLETION |
2 |
0.0041 |
| 37 |
GENITAL ERYTHEMA |
2 |
0.0040 |
| 38 |
INTERTRIGO |
2 |
0.0037 |
| 39 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
85 |
0.0036 |
| 40 |
PERIORBITAL HAEMATOMA |
3 |
0.0036 |
| 41 |
PSEUDOMEMBRANOUS COLITIS |
8 |
0.0036 |
| 42 |
EJECTION FRACTION |
2 |
0.0034 |
| 43 |
BILE DUCT STENOSIS |
4 |
0.0033 |
| 44 |
DYSMETRIA |
2 |
0.0033 |
| 45 |
HYPERKERATOSIS |
18 |
0.0033 |
| 46 |
METASTASES TO ADRENALS |
3 |
0.0033 |
| 47 |
BLOOD BILIRUBIN ABNORMAL |
4 |
0.0031 |
| 48 |
INTRACRANIAL HYPOTENSION |
2 |
0.0031 |
| 49 |
CHONDROCALCINOSIS |
2 |
0.0031 |
| 50 |
ENCEPHALITIS AUTOIMMUNE |
4 |
0.0030 |
| 51 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
2 |
0.0030 |
| 52 |
CHANGE OF BOWEL HABIT |
6 |
0.0029 |
| 53 |
RETINITIS |
5 |
0.0029 |
| 54 |
MONOCYTE PERCENTAGE INCREASED |
2 |
0.0028 |
| 55 |
SWOLLEN JOINT COUNT INCREASED |
9 |
0.0028 |
| 56 |
ALPHA 1 FOETOPROTEIN INCREASED |
2 |
0.0028 |
| 57 |
GALLBLADDER ENLARGEMENT |
3 |
0.0028 |
| 58 |
BLADDER DILATATION |
3 |
0.0028 |
| 59 |
LIP EROSION |
2 |
0.0027 |
| 60 |
BLOOD LOSS ANAEMIA |
6 |
0.0026 |
| 61 |
BRONCHITIS BACTERIAL |
2 |
0.0026 |
| 62 |
BASOPHIL COUNT INCREASED |
2 |
0.0026 |
| 63 |
COMPLICATION OF PREGNANCY |
2 |
0.0026 |
| 64 |
INCISION SITE PAIN |
3 |
0.0026 |
| 65 |
HAEMOPERITONEUM |
2 |
0.0025 |
| 66 |
IMMUNE-MEDIATED HEPATITIS |
5 |
0.0024 |
| 67 |
HYPERPARATHYROIDISM |
5 |
0.0024 |
| 68 |
CANCER PAIN |
6 |
0.0023 |
| 69 |
IMMUNE-MEDIATED ENTEROCOLITIS |
8 |
0.0022 |
| 70 |
ENTEROCOLITIS INFECTIOUS |
2 |
0.0022 |
| 71 |
INCISIONAL HERNIA |
3 |
0.0022 |
| 72 |
ESCHERICHIA BACTERAEMIA |
5 |
0.0021 |
| 73 |
HYPOPROTEINAEMIA |
4 |
0.0021 |
| 74 |
FOREIGN BODY IN EYE |
2 |
0.0021 |
| 75 |
LYMPHADENECTOMY |
2 |
0.0020 |
| 76 |
RHEUMATIC FEVER |
9 |
0.0020 |
| 77 |
CHOLANGIOCARCINOMA |
3 |
0.0020 |
| 78 |
DERMATITIS EXFOLIATIVE GENERALISED |
7 |
0.0020 |
| 79 |
HYPOPHYSITIS |
4 |
0.0020 |
| 80 |
ADHESION |
3 |
0.0020 |
| 81 |
EPICONDYLITIS |
3 |
0.0020 |
| 82 |
DYSAESTHESIA |
6 |
0.0020 |
| 83 |
METASTASES TO SKIN |
2 |
0.0019 |
| 84 |
ENTEROCOLITIS |
11 |
0.0019 |
| 85 |
RHEUMATOID FACTOR POSITIVE |
11 |
0.0019 |
| 86 |
PHARYNGEAL PARAESTHESIA |
3 |
0.0019 |
| 87 |
HYPERCHOLESTEROLAEMIA |
18 |
0.0019 |
| 88 |
CARDIAC AMYLOIDOSIS |
2 |
0.0018 |
| 89 |
AORTIC DILATATION |
2 |
0.0018 |
| 90 |
GASTRIC DILATATION |
3 |
0.0018 |
| 91 |
DERMATITIS EXFOLIATIVE |
9 |
0.0018 |
| 92 |
GASTROINTESTINAL ULCER HAEMORRHAGE |
2 |
0.0018 |
| 93 |
CARBON DIOXIDE DECREASED |
2 |
0.0017 |
| 94 |
OTORRHOEA |
3 |
0.0017 |
| 95 |
GROIN ABSCESS |
2 |
0.0017 |
| 96 |
BONE EROSION |
6 |
0.0017 |
| 97 |
UTERINE POLYP |
3 |
0.0017 |
| 98 |
DYSPLASIA |
2 |
0.0017 |
| 99 |
THYROIDITIS |
5 |
0.0017 |
| 100 |
FURUNCLE |
13 |
0.0016 |
| 101 |
ESSENTIAL HYPERTENSION |
3 |
0.0016 |
| 102 |
ORAL MUCOSA EROSION |
2 |
0.0016 |
| 103 |
SMALL INTESTINAL PERFORATION |
3 |
0.0016 |
| 104 |
MALLORY-WEISS SYNDROME |
2 |
0.0016 |
| 105 |
LIP HAEMORRHAGE |
2 |
0.0016 |
| 106 |
ADRENAL INSUFFICIENCY |
19 |
0.0016 |
| 107 |
OBSTRUCTION GASTRIC |
2 |
0.0016 |
| 108 |
LIVER ABSCESS |
5 |
0.0015 |
| 109 |
DERMATITIS BULLOUS |
11 |
0.0015 |
| 110 |
SKIN PAPILLOMA |
6 |
0.0015 |
| 111 |
ULCER HAEMORRHAGE |
10 |
0.0015 |
| 112 |
NIPPLE PAIN |
3 |
0.0015 |
| 113 |
HELICOBACTER INFECTION |
15 |
0.0015 |
| 114 |
MENINGITIS VIRAL |
2 |
0.0015 |
| 115 |
PEMPHIGOID |
11 |
0.0015 |
| 116 |
NAIL INFECTION |
2 |
0.0014 |
| 117 |
MYOPATHY |
12 |
0.0014 |
| 118 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
9 |
0.0014 |
| 119 |
ONYCHOMYCOSIS |
6 |
0.0014 |
| 120 |
HYPOMANIA |
5 |
0.0014 |
| 121 |
RHINITIS ALLERGIC |
6 |
0.0013 |
| 122 |
ABNORMAL FAECES |
11 |
0.0013 |
| 123 |
PROTEIN TOTAL DECREASED |
5 |
0.0013 |
| 124 |
DISLOCATION OF VERTEBRA |
3 |
0.0013 |
| 125 |
PERFORMANCE STATUS DECREASED |
6 |
0.0013 |
| 126 |
BILIRUBIN CONJUGATED INCREASED |
3 |
0.0013 |
| 127 |
BLOOD CREATININE DECREASED |
4 |
0.0013 |
| 128 |
OPHTHALMOPLEGIA |
2 |
0.0013 |
| 129 |
URINARY TRACT OBSTRUCTION |
3 |
0.0013 |
| 130 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
9 |
0.0013 |
| 131 |
NASAL ULCER |
2 |
0.0013 |
| 132 |
SKIN TOXICITY |
7 |
0.0012 |
| 133 |
DUODENAL ULCER PERFORATION |
9 |
0.0012 |
| 134 |
OBESITY |
19 |
0.0012 |
| 135 |
METASTASES TO SPINE |
4 |
0.0012 |
| 136 |
METASTASES TO PERITONEUM |
3 |
0.0012 |
| 137 |
HEPATIC ENCEPHALOPATHY |
11 |
0.0012 |
| 138 |
BLOOD AMYLASE INCREASED |
2 |
0.0012 |
| 139 |
AORTIC ARTERIOSCLEROSIS |
3 |
0.0012 |
| 140 |
PHYSICAL DECONDITIONING |
3 |
0.0012 |
| 141 |
PUSTULAR PSORIASIS |
4 |
0.0012 |
| 142 |
CERVICAL SPINAL STENOSIS |
2 |
0.0012 |
| 143 |
ACTINIC KERATOSIS |
3 |
0.0012 |
| 144 |
LARYNGOSPASM |
3 |
0.0011 |
| 145 |
MAJOR DEPRESSION |
8 |
0.0011 |
| 146 |
MEAN CELL HAEMOGLOBIN DECREASED |
2 |
0.0011 |
| 147 |
C-REACTIVE PROTEIN ABNORMAL |
7 |
0.0011 |
| 148 |
MUSCLE INJURY |
9 |
0.0011 |
| 149 |
OTOTOXICITY |
2 |
0.0011 |
| 150 |
NASAL OBSTRUCTION |
2 |
0.0011 |
| 151 |
BLOOD IRON INCREASED |
2 |
0.0011 |
| 152 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
3 |
0.0011 |
| 153 |
HEPATOCELLULAR CARCINOMA |
8 |
0.0011 |
| 154 |
GENERALISED OEDEMA |
13 |
0.0010 |
| 155 |
GASTROINTESTINAL TOXICITY |
5 |
0.0010 |
| 156 |
ARTERIAL THROMBOSIS |
2 |
0.0010 |
| 157 |
AUTOIMMUNE DISORDER |
10 |
0.0010 |
| 158 |
NECK INJURY |
3 |
0.0010 |
| 159 |
HYPERAEMIA |
2 |
0.0010 |
| 160 |
ODYNOPHAGIA |
6 |
0.0010 |
| 161 |
ANORECTAL DISORDER |
2 |
0.0010 |
| 162 |
REBOUND ACID HYPERSECRETION |
3 |
0.0010 |
| 163 |
PENILE PAIN |
3 |
0.0010 |
| 164 |
PATHOLOGICAL FRACTURE |
5 |
0.0010 |
| 165 |
DYSCHEZIA |
3 |
0.0010 |
| 166 |
DERMATITIS PSORIASIFORM |
2 |
0.0010 |
| 167 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
2 |
0.0010 |
| 168 |
SECOND PRIMARY MALIGNANCY |
8 |
0.0010 |
| 169 |
BODY TEMPERATURE FLUCTUATION |
2 |
0.0010 |
| 170 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 171 |
MUSCLE FATIGUE |
4 |
0.0009 |
| 172 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
2 |
0.0009 |
| 173 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 174 |
HORDEOLUM |
4 |
0.0009 |
| 175 |
CALCINOSIS |
2 |
0.0009 |
| 176 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
2 |
0.0009 |
| 177 |
WOUND DEHISCENCE |
3 |
0.0009 |
| 178 |
LIP DRY |
8 |
0.0009 |
| 179 |
PEMPHIGUS |
11 |
0.0009 |
| 180 |
PRESCRIBED OVERDOSE |
17 |
0.0009 |
| 181 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
9 |
0.0009 |
| 182 |
LICHENOID KERATOSIS |
2 |
0.0009 |
| 183 |
LEFT VENTRICULAR FAILURE |
3 |
0.0009 |
| 184 |
DROOLING |
6 |
0.0009 |
| 185 |
MOUTH SWELLING |
5 |
0.0009 |
| 186 |
NEPHROGENIC ANAEMIA |
4 |
0.0009 |
| 187 |
HYPOMAGNESAEMIA |
12 |
0.0009 |
| 188 |
FOLLICULITIS |
9 |
0.0009 |
| 189 |
CLOSTRIDIUM DIFFICILE COLITIS |
9 |
0.0008 |
| 190 |
INGROWING NAIL |
2 |
0.0008 |
| 191 |
SKIN ABRASION |
4 |
0.0008 |
| 192 |
GLOSSITIS |
3 |
0.0008 |
| 193 |
TASTE DISORDER |
17 |
0.0008 |
| 194 |
GAIT INABILITY |
28 |
0.0008 |
| 195 |
SCLERODERMA |
3 |
0.0008 |
| 196 |
END STAGE RENAL DISEASE |
15 |
0.0008 |
| 197 |
HAEMATOLOGICAL INFECTION |
2 |
0.0008 |
| 198 |
SCIATICA |
13 |
0.0008 |
| 199 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0008 |
| 200 |
KNEE ARTHROPLASTY |
17 |
0.0008 |
| 201 |
PRE-EXISTING CONDITION IMPROVED |
5 |
0.0008 |
| 202 |
HYPERPARATHYROIDISM SECONDARY |
2 |
0.0008 |
| 203 |
C-REACTIVE PROTEIN INCREASED |
29 |
0.0008 |
| 204 |
OSTEITIS |
2 |
0.0008 |
| 205 |
HYPOCALCAEMIA |
15 |
0.0008 |
| 206 |
DYSLIPIDAEMIA |
4 |
0.0008 |
| 207 |
APPENDICITIS PERFORATED |
2 |
0.0008 |
| 208 |
THYROID MASS |
3 |
0.0008 |
| 209 |
MEAN CELL VOLUME INCREASED |
2 |
0.0008 |
| 210 |
BLOOD CHLORIDE DECREASED |
2 |
0.0008 |
| 211 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 212 |
FAECES HARD |
3 |
0.0008 |
| 213 |
EYE DISCHARGE |
8 |
0.0008 |
| 214 |
EXOSTOSIS |
7 |
0.0008 |
| 215 |
PROSTATOMEGALY |
3 |
0.0008 |
| 216 |
NAIL DISCOLOURATION |
3 |
0.0008 |
| 217 |
EXFOLIATIVE RASH |
2 |
0.0008 |
| 218 |
NERVE COMPRESSION |
7 |
0.0008 |
| 219 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 220 |
ERYTHEMA MULTIFORME |
7 |
0.0007 |
| 221 |
SKIN ULCER |
19 |
0.0007 |
| 222 |
GLOMERULAR FILTRATION RATE DECREASED |
9 |
0.0007 |
| 223 |
ONYCHOCLASIS |
5 |
0.0007 |
| 224 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 225 |
MACULE |
2 |
0.0007 |
| 226 |
LIVE BIRTH |
6 |
0.0007 |
| 227 |
DERMATITIS |
15 |
0.0007 |
| 228 |
WOUND |
20 |
0.0007 |
| 229 |
DERMATITIS ALLERGIC |
9 |
0.0007 |
| 230 |
GLOSSODYNIA |
16 |
0.0007 |
| 231 |
ELECTRIC SHOCK SENSATION |
2 |
0.0007 |
| 232 |
PULMONARY TOXICITY |
5 |
0.0007 |
| 233 |
CHOLECYSTITIS ACUTE |
4 |
0.0007 |
| 234 |
UTERINE HAEMORRHAGE |
3 |
0.0007 |
| 235 |
NEUTROPHILIA |
4 |
0.0007 |
| 236 |
HEART VALVE INCOMPETENCE |
2 |
0.0007 |
| 237 |
BLOOD MAGNESIUM DECREASED |
6 |
0.0007 |
| 238 |
HEPATIC LESION |
3 |
0.0007 |
| 239 |
FINE MOTOR SKILL DYSFUNCTION |
2 |
0.0007 |
| 240 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 241 |
STAPHYLOCOCCAL BACTERAEMIA |
3 |
0.0007 |
| 242 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 243 |
HAND DEFORMITY |
9 |
0.0007 |
| 244 |
DIVERTICULUM INTESTINAL |
3 |
0.0007 |
| 245 |
NAIL DISORDER |
6 |
0.0007 |
| 246 |
LUMBAR SPINAL STENOSIS |
2 |
0.0007 |
| 247 |
MOUTH HAEMORRHAGE |
5 |
0.0007 |
| 248 |
ABDOMINAL ABSCESS |
3 |
0.0007 |
| 249 |
PHYSICAL DISABILITY |
3 |
0.0007 |
| 250 |
HYPOPHOSPHATAEMIA |
5 |
0.0007 |
| 251 |
BLOOD BILIRUBIN INCREASED |
18 |
0.0007 |
| 252 |
SKIN FISSURES |
13 |
0.0007 |
| 253 |
TYPE 1 DIABETES MELLITUS |
4 |
0.0007 |
| 254 |
SUSPECTED OFF LABEL USE |
3 |
0.0007 |
| 255 |
LUPUS-LIKE SYNDROME |
6 |
0.0007 |
| 256 |
HIP ARTHROPLASTY |
10 |
0.0007 |
| 257 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
6 |
0.0007 |
| 258 |
CHOLANGITIS |
4 |
0.0006 |
| 259 |
HYPOALBUMINAEMIA |
5 |
0.0006 |
| 260 |
YELLOW SKIN |
3 |
0.0006 |
| 261 |
PRODUCT ADMINISTRATION INTERRUPTED |
5 |
0.0006 |
| 262 |
EOSINOPHILIC PNEUMONIA |
2 |
0.0006 |
| 263 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
0.0006 |
| 264 |
NON-CARDIAC CHEST PAIN |
2 |
0.0006 |
| 265 |
STOMATITIS |
38 |
0.0006 |
| 266 |
ENTERITIS |
4 |
0.0006 |
| 267 |
LOWER LIMB FRACTURE |
12 |
0.0006 |
| 268 |
PNEUMONITIS |
17 |
0.0006 |
| 269 |
FIBROMYALGIA |
15 |
0.0006 |
| 270 |
HERPES SIMPLEX |
4 |
0.0006 |
| 271 |
HORMONE LEVEL ABNORMAL |
3 |
0.0006 |
| 272 |
RENAL CELL CARCINOMA |
3 |
0.0006 |
| 273 |
HEPATIC NEOPLASM |
2 |
0.0006 |
| 274 |
METASTASES TO LUNG |
7 |
0.0006 |
| 275 |
PROTEIN URINE PRESENT |
3 |
0.0006 |
| 276 |
TOXIC ENCEPHALOPATHY |
3 |
0.0006 |
| 277 |
HEPATIC CYST |
2 |
0.0006 |
| 278 |
ENDOCARDITIS |
3 |
0.0006 |
| 279 |
NEPHROTIC SYNDROME |
4 |
0.0006 |
| 280 |
VARICOSE VEIN |
3 |
0.0006 |
| 281 |
ORAL PAIN |
13 |
0.0006 |
| 282 |
IMPAIRED HEALING |
19 |
0.0006 |
| 283 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 284 |
ENCEPHALITIS |
4 |
0.0006 |
| 285 |
ARTHROPATHY |
32 |
0.0006 |
| 286 |
AUTOIMMUNE HEPATITIS |
4 |
0.0006 |
| 287 |
MUCOSAL INFLAMMATION |
15 |
0.0006 |
| 288 |
FEBRILE NEUTROPENIA |
38 |
0.0006 |
| 289 |
LOWER RESPIRATORY TRACT INFECTION |
26 |
0.0006 |
| 290 |
ERYTHEMA NODOSUM |
2 |
0.0006 |
| 291 |
SPINAL OSTEOARTHRITIS |
5 |
0.0006 |
| 292 |
POLYARTHRITIS |
3 |
0.0006 |
| 293 |
HYPONATRAEMIA |
32 |
0.0006 |
| 294 |
PAPULE |
4 |
0.0006 |
| 295 |
JOINT DISLOCATION |
6 |
0.0006 |
| 296 |
JAUNDICE CHOLESTATIC |
2 |
0.0006 |
| 297 |
HAEMORRHAGE SUBCUTANEOUS |
2 |
0.0006 |
| 298 |
MACULOPATHY |
2 |
0.0006 |
| 299 |
ILEUS |
7 |
0.0006 |
| 300 |
IRRITABLE BOWEL SYNDROME |
12 |
0.0006 |
| 301 |
HAEMATOCRIT DECREASED |
11 |
0.0006 |
| 302 |
BONE LESION |
2 |
0.0006 |
| 303 |
CHEILITIS |
3 |
0.0006 |
| 304 |
ABDOMINAL PAIN LOWER |
14 |
0.0006 |
| 305 |
PRESCRIBED UNDERDOSE |
11 |
0.0006 |
| 306 |
UTERINE LEIOMYOMA |
4 |
0.0005 |
| 307 |
SKIN LESION |
15 |
0.0005 |
| 308 |
FOOD INTOLERANCE |
2 |
0.0005 |
| 309 |
ASTHENOPIA |
3 |
0.0005 |
| 310 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
6 |
0.0005 |
| 311 |
UROSEPSIS |
5 |
0.0005 |
| 312 |
BLOOD GLUCOSE ABNORMAL |
10 |
0.0005 |
| 313 |
GASTRIC ULCER HAEMORRHAGE |
3 |
0.0005 |
| 314 |
FOOT DEFORMITY |
6 |
0.0005 |
| 315 |
NEURODERMATITIS |
2 |
0.0005 |
| 316 |
INTERMENSTRUAL BLEEDING |
3 |
0.0005 |
| 317 |
PERICARDITIS |
9 |
0.0005 |
| 318 |
SQUAMOUS CELL CARCINOMA |
5 |
0.0005 |
| 319 |
CONJUNCTIVAL HAEMORRHAGE |
2 |
0.0005 |
| 320 |
CLAVICLE FRACTURE |
2 |
0.0005 |
| 321 |
PARANOIA |
9 |
0.0005 |
| 322 |
SKIN ATROPHY |
3 |
0.0005 |
| 323 |
GINGIVAL DISORDER |
2 |
0.0005 |
| 324 |
BLOOD URIC ACID INCREASED |
3 |
0.0005 |
| 325 |
OSTEOARTHRITIS |
22 |
0.0005 |
| 326 |
CELLULITIS |
26 |
0.0005 |
| 327 |
BLOOD CHOLESTEROL INCREASED |
24 |
0.0005 |
| 328 |
PHARYNGEAL SWELLING |
5 |
0.0005 |
| 329 |
SKIN EXFOLIATION |
43 |
0.0005 |
| 330 |
LYMPHOCYTE COUNT DECREASED |
9 |
0.0005 |
| 331 |
HEPATIC FUNCTION ABNORMAL |
19 |
0.0005 |
| 332 |
HYPOPHAGIA |
13 |
0.0005 |
| 333 |
DRUG ERUPTION |
9 |
0.0005 |
| 334 |
HYPERLIPIDAEMIA |
6 |
0.0005 |
| 335 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 336 |
SYNOVITIS |
9 |
0.0005 |
| 337 |
BLOOD POTASSIUM DECREASED |
15 |
0.0005 |
| 338 |
HYPOKALAEMIA |
23 |
0.0005 |
| 339 |
OEDEMA |
27 |
0.0005 |
| 340 |
PLATELET COUNT ABNORMAL |
3 |
0.0005 |
| 341 |
INJECTION SITE VESICLES |
3 |
0.0005 |
| 342 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 343 |
PSORIATIC ARTHROPATHY |
20 |
0.0005 |
| 344 |
POLYURIA |
4 |
0.0005 |
| 345 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
12 |
0.0005 |
| 346 |
ACUTE CORONARY SYNDROME |
4 |
0.0005 |
| 347 |
DECREASED APPETITE |
111 |
0.0005 |
| 348 |
BLOOD SODIUM DECREASED |
9 |
0.0005 |
| 349 |
ONYCHOMADESIS |
2 |
0.0005 |
| 350 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0005 |
| 351 |
TYPE 2 DIABETES MELLITUS |
16 |
0.0005 |
| 352 |
SENSATION OF FOREIGN BODY |
4 |
0.0005 |
| 353 |
SKIN PLAQUE |
4 |
0.0005 |
| 354 |
HYPOTHYROIDISM |
15 |
0.0005 |
| 355 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 356 |
INTERVERTEBRAL DISC DISORDER |
2 |
0.0005 |
| 357 |
PROCTALGIA |
3 |
0.0005 |
| 358 |
HAEMOGLOBIN ABNORMAL |
3 |
0.0005 |
| 359 |
NEUTROPHIL COUNT DECREASED |
19 |
0.0005 |
| 360 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 361 |
ORTHOSTATIC HYPOTENSION |
8 |
0.0005 |
| 362 |
WALKING AID USER |
3 |
0.0005 |
| 363 |
GRIP STRENGTH DECREASED |
4 |
0.0005 |
| 364 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
10 |
0.0005 |
| 365 |
CATHETERISATION CARDIAC |
2 |
0.0005 |
| 366 |
CYTOKINE RELEASE SYNDROME |
9 |
0.0004 |
| 367 |
ILEUS PARALYTIC |
2 |
0.0004 |
| 368 |
MALNUTRITION |
5 |
0.0004 |
| 369 |
BREAST MASS |
3 |
0.0004 |
| 370 |
MYOSITIS |
4 |
0.0004 |
| 371 |
THERAPY NON-RESPONDER |
20 |
0.0004 |
| 372 |
FREQUENT BOWEL MOVEMENTS |
12 |
0.0004 |
| 373 |
DRUG EFFECT DELAYED |
2 |
0.0004 |
| 374 |
GINGIVAL BLEEDING |
6 |
0.0004 |
| 375 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 376 |
SCAB |
5 |
0.0004 |
| 377 |
INCREASED TENDENCY TO BRUISE |
4 |
0.0004 |
| 378 |
EYE OPERATION |
2 |
0.0004 |
| 379 |
LYMPHOEDEMA |
3 |
0.0004 |
| 380 |
ARTHRITIS INFECTIVE |
2 |
0.0004 |
| 381 |
DEFAECATION URGENCY |
3 |
0.0004 |
| 382 |
FLANK PAIN |
4 |
0.0004 |
| 383 |
HEPATIC CIRRHOSIS |
8 |
0.0004 |
| 384 |
DUODENAL ULCER |
3 |
0.0004 |
| 385 |
DYSPNOEA EXERTIONAL |
16 |
0.0004 |
| 386 |
BLOOD IRON DECREASED |
5 |
0.0004 |
| 387 |
NEUTROPENIC SEPSIS |
3 |
0.0004 |
| 388 |
FAECAL INCONTINENCE |
2 |
0.0004 |
| 389 |
ATELECTASIS |
4 |
0.0004 |
| 390 |
GASTROENTERITIS |
6 |
0.0004 |
| 391 |
ORAL DISORDER |
3 |
0.0004 |
| 392 |
LIVER INJURY |
10 |
0.0004 |
| 393 |
SENSITIVE SKIN |
3 |
0.0004 |
| 394 |
SMALL INTESTINAL OBSTRUCTION |
5 |
0.0004 |
| 395 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 396 |
LIGAMENT SPRAIN |
4 |
0.0004 |
| 397 |
FOOT OPERATION |
2 |
0.0004 |
| 398 |
DIABETIC NEUROPATHY |
2 |
0.0004 |
| 399 |
GASTROINTESTINAL SOUNDS ABNORMAL |
2 |
0.0004 |
| 400 |
PHARYNGITIS |
5 |
0.0004 |
| 401 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 402 |
ERYSIPELAS |
2 |
0.0004 |
| 403 |
ECONOMIC PROBLEM |
6 |
0.0004 |
| 404 |
OSTEOPENIA |
6 |
0.0004 |
| 405 |
TOXIC EPIDERMAL NECROLYSIS |
6 |
0.0004 |
| 406 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
| 407 |
CHRONIC KIDNEY DISEASE |
30 |
0.0004 |
| 408 |
TOOTH ABSCESS |
4 |
0.0004 |
| 409 |
AMMONIA INCREASED |
2 |
0.0004 |
| 410 |
LIPASE INCREASED |
3 |
0.0004 |
| 411 |
GOUT |
7 |
0.0004 |
| 412 |
SKIN DISORDER |
13 |
0.0004 |
| 413 |
ATRIOVENTRICULAR BLOCK |
3 |
0.0004 |
| 414 |
APHTHOUS ULCER |
3 |
0.0004 |
| 415 |
DIPLOPIA |
10 |
0.0004 |
| 416 |
PANIC ATTACK |
14 |
0.0004 |
| 417 |
ROAD TRAFFIC ACCIDENT |
16 |
0.0004 |
| 418 |
HEPATIC ENZYME INCREASED |
26 |
0.0004 |
| 419 |
DYSURIA |
14 |
0.0004 |
| 420 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 421 |
GINGIVAL PAIN |
3 |
0.0004 |
| 422 |
NYSTAGMUS |
2 |
0.0004 |
| 423 |
PERIPHERAL SWELLING |
58 |
0.0004 |
| 424 |
ABDOMINAL DISCOMFORT |
63 |
0.0004 |
| 425 |
METABOLIC ACIDOSIS |
12 |
0.0004 |
| 426 |
ASCITES |
11 |
0.0004 |
| 427 |
OBSESSIVE-COMPULSIVE DISORDER |
3 |
0.0004 |
| 428 |
NEOPLASM PROGRESSION |
13 |
0.0004 |
| 429 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
0.0004 |
| 430 |
FOOD POISONING |
2 |
0.0004 |
| 431 |
SENSORY LOSS |
3 |
0.0004 |
| 432 |
ACUTE KIDNEY INJURY |
57 |
0.0004 |
| 433 |
OVERWEIGHT |
2 |
0.0004 |
| 434 |
STENT PLACEMENT |
3 |
0.0004 |
| 435 |
ANAL ABSCESS |
2 |
0.0004 |
| 436 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 437 |
GASTRIC ULCER |
7 |
0.0004 |
| 438 |
HYPERTENSION |
78 |
0.0004 |
| 439 |
SEPTIC SHOCK |
16 |
0.0004 |
| 440 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 441 |
HICCUPS |
3 |
0.0004 |
| 442 |
WOUND INFECTION |
4 |
0.0004 |
| 443 |
UPPER-AIRWAY COUGH SYNDROME |
3 |
0.0004 |
| 444 |
SPINAL COMPRESSION FRACTURE |
3 |
0.0004 |
| 445 |
MENSTRUAL DISORDER |
3 |
0.0004 |
| 446 |
ALANINE AMINOTRANSFERASE INCREASED |
22 |
0.0004 |
| 447 |
ASPARTATE AMINOTRANSFERASE INCREASED |
19 |
0.0004 |
| 448 |
ANGIOPATHY |
2 |
0.0004 |
| 449 |
SKIN INFECTION |
4 |
0.0004 |
| 450 |
BLISTER |
20 |
0.0004 |
| 451 |
MITRAL VALVE INCOMPETENCE |
4 |
0.0004 |
| 452 |
PSORIASIS |
46 |
0.0004 |
| 453 |
HEPATITIS |
9 |
0.0004 |
| 454 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 455 |
VITAMIN D DECREASED |
3 |
0.0004 |
| 456 |
SKIN DISCOLOURATION |
16 |
0.0003 |
| 457 |
MUSCLE TWITCHING |
8 |
0.0003 |
| 458 |
MUSCLE STRAIN |
3 |
0.0003 |
| 459 |
HYPERTHYROIDISM |
5 |
0.0003 |
| 460 |
FEEDING DISORDER |
7 |
0.0003 |
| 461 |
SWELLING |
32 |
0.0003 |
| 462 |
DECREASED INTEREST |
2 |
0.0003 |
| 463 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
2 |
0.0003 |
| 464 |
SKIN HAEMORRHAGE |
5 |
0.0003 |
| 465 |
BACTERAEMIA |
4 |
0.0003 |
| 466 |
OEDEMA PERIPHERAL |
41 |
0.0003 |
| 467 |
CHOLECYSTITIS |
4 |
0.0003 |
| 468 |
CARDIAC PACEMAKER INSERTION |
2 |
0.0003 |
| 469 |
POLYNEUROPATHY |
4 |
0.0003 |
| 470 |
HEPATIC FAILURE |
10 |
0.0003 |
| 471 |
LEUKOCYTOSIS |
6 |
0.0003 |
| 472 |
DRUG INTOLERANCE |
32 |
0.0003 |
| 473 |
BURSITIS |
4 |
0.0003 |
| 474 |
INGUINAL HERNIA |
2 |
0.0003 |
| 475 |
PLATELET COUNT DECREASED |
35 |
0.0003 |
| 476 |
EPILEPSY |
10 |
0.0003 |
| 477 |
PNEUMONIA BACTERIAL |
3 |
0.0003 |
| 478 |
DYSPHAGIA |
31 |
0.0003 |
| 479 |
IRON DEFICIENCY ANAEMIA |
3 |
0.0003 |
| 480 |
UPPER RESPIRATORY TRACT INFECTION |
15 |
0.0003 |
| 481 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 482 |
BREAST CANCER STAGE I |
3 |
0.0003 |
| 483 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 484 |
HAIR COLOUR CHANGES |
4 |
0.0003 |
| 485 |
APPENDICITIS |
3 |
0.0003 |
| 486 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 487 |
BASAL CELL CARCINOMA |
5 |
0.0003 |
| 488 |
SWOLLEN TONGUE |
10 |
0.0003 |
| 489 |
BRAIN FOG |
5 |
0.0003 |
| 490 |
PROTEINURIA |
6 |
0.0003 |
| 491 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
5 |
0.0003 |
| 492 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 493 |
MALIGNANT NEOPLASM PROGRESSION |
32 |
0.0003 |
| 494 |
SLEEP DISORDER |
22 |
0.0003 |
| 495 |
ROTATOR CUFF SYNDROME |
4 |
0.0003 |
| 496 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
4 |
0.0003 |
| 497 |
LIVER FUNCTION TEST ABNORMAL |
9 |
0.0003 |
| 498 |
HAEMORRHOIDS |
6 |
0.0003 |
| 499 |
JOINT STIFFNESS |
8 |
0.0003 |
| 500 |
PHOTOSENSITIVITY REACTION |
5 |
0.0003 |
| 501 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 502 |
HYPERGLYCAEMIA |
11 |
0.0003 |
| 503 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 504 |
INFUSION RELATED REACTION |
20 |
0.0003 |
| 505 |
APPETITE DISORDER |
2 |
0.0003 |
| 506 |
DIARRHOEA |
194 |
0.0003 |
| 507 |
OVARIAN CYST |
3 |
0.0003 |
| 508 |
URINARY RETENTION |
10 |
0.0003 |
| 509 |
PREGNANCY |
6 |
0.0003 |
| 510 |
ATRIOVENTRICULAR BLOCK COMPLETE |
2 |
0.0003 |
| 511 |
MALIGNANT MELANOMA |
4 |
0.0003 |
| 512 |
TOXIC SKIN ERUPTION |
3 |
0.0003 |
| 513 |
HYPOTHERMIA |
3 |
0.0003 |
| 514 |
GENERAL PHYSICAL CONDITION ABNORMAL |
2 |
0.0003 |
| 515 |
ABNORMAL LOSS OF WEIGHT |
2 |
0.0003 |
| 516 |
LIVER DISORDER |
13 |
0.0003 |
| 517 |
EAR DISCOMFORT |
3 |
0.0003 |
| 518 |
DRY SKIN |
39 |
0.0003 |
| 519 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
| 520 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0003 |
| 521 |
TEMPERATURE INTOLERANCE |
3 |
0.0003 |
| 522 |
COLITIS |
11 |
0.0003 |
| 523 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 524 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 525 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 526 |
INTENTIONAL PRODUCT USE ISSUE |
25 |
0.0003 |
| 527 |
NEUROTOXICITY |
5 |
0.0003 |
| 528 |
METASTASES TO LIVER |
5 |
0.0003 |
| 529 |
HALLUCINATION, VISUAL |
6 |
0.0003 |
| 530 |
DISSEMINATED INTRAVASCULAR COAGULATION |
4 |
0.0003 |
| 531 |
DRY MOUTH |
23 |
0.0003 |
| 532 |
SEASONAL ALLERGY |
4 |
0.0003 |
| 533 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
10 |
0.0003 |
| 534 |
DRY EYE |
14 |
0.0003 |
| 535 |
METASTASIS |
2 |
0.0003 |
| 536 |
CEREBRAL HAEMORRHAGE |
10 |
0.0003 |
| 537 |
POOR QUALITY SLEEP |
6 |
0.0003 |
| 538 |
MOBILITY DECREASED |
20 |
0.0003 |
| 539 |
ADVERSE DRUG REACTION |
25 |
0.0003 |
| 540 |
ANAEMIA |
53 |
0.0003 |
| 541 |
TOOTHACHE |
5 |
0.0003 |
| 542 |
OSTEOMYELITIS |
5 |
0.0003 |
| 543 |
INTENTIONAL PRODUCT MISUSE |
24 |
0.0003 |
| 544 |
DYSPHONIA |
16 |
0.0003 |
| 545 |
SINUSITIS |
28 |
0.0003 |
| 546 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 547 |
TOOTH DISORDER |
6 |
0.0003 |
| 548 |
INTERSTITIAL LUNG DISEASE |
13 |
0.0003 |
| 549 |
COLON CANCER |
4 |
0.0003 |
| 550 |
OSTEOPOROSIS |
11 |
0.0003 |
| 551 |
INTESTINAL PERFORATION |
3 |
0.0003 |
| 552 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 553 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
| 554 |
REBOUND EFFECT |
3 |
0.0003 |
| 555 |
BLOOD URINE PRESENT |
5 |
0.0003 |
| 556 |
EAR INFECTION |
7 |
0.0003 |
| 557 |
HAEMATURIA |
9 |
0.0003 |
| 558 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 559 |
HYPERTHERMIA |
2 |
0.0003 |
| 560 |
SKIN IRRITATION |
12 |
0.0003 |
| 561 |
PAIN IN EXTREMITY |
77 |
0.0003 |
| 562 |
RASH |
113 |
0.0003 |
| 563 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 564 |
ABDOMINAL PAIN |
60 |
0.0003 |
| 565 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 566 |
ACUTE MYELOID LEUKAEMIA |
4 |
0.0003 |
| 567 |
SPLENOMEGALY |
3 |
0.0003 |
| 568 |
GASTROINTESTINAL INFLAMMATION |
2 |
0.0003 |
| 569 |
DRUG-INDUCED LIVER INJURY |
8 |
0.0003 |
| 570 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 571 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 572 |
PNEUMOTHORAX |
4 |
0.0003 |
| 573 |
ABSCESS |
4 |
0.0003 |
| 574 |
PANCYTOPENIA |
14 |
0.0003 |
| 575 |
WRIST FRACTURE |
3 |
0.0003 |
| 576 |
CONTUSION |
24 |
0.0002 |
| 577 |
THYROID CANCER |
3 |
0.0002 |
| 578 |
BLOOD PRESSURE INCREASED |
38 |
0.0002 |
| 579 |
NIGHT SWEATS |
8 |
0.0002 |
| 580 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0002 |
| 581 |
NOCTURIA |
3 |
0.0002 |
| 582 |
DISCOMFORT |
15 |
0.0002 |
| 583 |
PYREXIA |
85 |
0.0002 |
| 584 |
DECUBITUS ULCER |
2 |
0.0002 |
| 585 |
HYPERAESTHESIA |
2 |
0.0002 |
| 586 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 587 |
SEPSIS |
27 |
0.0002 |
| 588 |
GENERAL PHYSICAL HEALTH DETERIORATION |
28 |
0.0002 |
| 589 |
WEIGHT DECREASED |
67 |
0.0002 |
| 590 |
RHABDOMYOLYSIS |
10 |
0.0002 |
| 591 |
SECRETION DISCHARGE |
3 |
0.0002 |
| 592 |
FATIGUE |
186 |
0.0002 |
| 593 |
BLOOD UREA INCREASED |
4 |
0.0002 |
| 594 |
HAEMODIALYSIS |
2 |
0.0002 |
| 595 |
EYE PRURITUS |
8 |
0.0002 |
| 596 |
FACE OEDEMA |
4 |
0.0002 |
| 597 |
CONDITION AGGRAVATED |
72 |
0.0002 |
| 598 |
DISEASE PROGRESSION |
28 |
0.0002 |
| 599 |
RENAL INJURY |
7 |
0.0002 |
| 600 |
JOINT INJURY |
5 |
0.0002 |
| 601 |
DRUG RESISTANCE |
6 |
0.0002 |
| 602 |
RENAL FAILURE |
31 |
0.0002 |
| 603 |
INFLAMMATION |
12 |
0.0002 |
| 604 |
DEHYDRATION |
31 |
0.0002 |
| 605 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 606 |
JOINT SWELLING |
28 |
0.0002 |
| 607 |
HIATUS HERNIA |
3 |
0.0002 |
| 608 |
INJECTION SITE INDURATION |
3 |
0.0002 |
| 609 |
NEUROPATHY PERIPHERAL |
22 |
0.0002 |
| 610 |
CONTRAINDICATED PRODUCT ADMINISTERED |
7 |
0.0002 |
| 611 |
THERAPEUTIC RESPONSE DECREASED |
14 |
0.0002 |
| 612 |
DELIRIUM |
8 |
0.0002 |
| 613 |
PLATELET COUNT INCREASED |
3 |
0.0002 |
| 614 |
ALOPECIA |
45 |
0.0002 |
| 615 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 616 |
ADVERSE EVENT |
21 |
0.0002 |
| 617 |
DISORIENTATION |
9 |
0.0002 |
| 618 |
LUNG INFILTRATION |
2 |
0.0002 |
| 619 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 620 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 621 |
VOMITING |
106 |
0.0002 |
| 622 |
RASH MACULO-PAPULAR |
5 |
0.0002 |
| 623 |
HEPATOTOXICITY |
5 |
0.0002 |
| 624 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 625 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0002 |
| 626 |
GASTROINTESTINAL DISORDER |
20 |
0.0002 |
| 627 |
CONFUSIONAL STATE |
36 |
0.0002 |
| 628 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 629 |
SINUS CONGESTION |
3 |
0.0002 |
| 630 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 631 |
HEAD INJURY |
7 |
0.0002 |
| 632 |
PALLOR |
6 |
0.0002 |
| 633 |
ERYTHEMA |
45 |
0.0002 |
| 634 |
ABDOMINAL PAIN UPPER |
45 |
0.0002 |
| 635 |
URINARY TRACT INFECTION |
37 |
0.0002 |
| 636 |
POLLAKIURIA |
9 |
0.0002 |
| 637 |
HAEMOPTYSIS |
6 |
0.0002 |
| 638 |
COORDINATION ABNORMAL |
3 |
0.0002 |
| 639 |
NECK PAIN |
12 |
0.0002 |
| 640 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 641 |
HYPOTENSION |
43 |
0.0002 |
| 642 |
HAEMOGLOBIN DECREASED |
22 |
0.0002 |
| 643 |
COGNITIVE DISORDER |
10 |
0.0002 |
| 644 |
ILL-DEFINED DISORDER |
13 |
0.0002 |
| 645 |
PLEURAL EFFUSION |
13 |
0.0002 |
| 646 |
SKIN REACTION |
3 |
0.0002 |
| 647 |
LACERATION |
2 |
0.0002 |
| 648 |
ARTERIOSCLEROSIS |
2 |
0.0002 |
| 649 |
LYMPHOPENIA |
3 |
0.0002 |
| 650 |
ABDOMINAL DISTENSION |
22 |
0.0002 |
| 651 |
HAEMATOTOXICITY |
2 |
0.0002 |
| 652 |
ECZEMA |
11 |
0.0002 |
| 653 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 654 |
INCREASED APPETITE |
4 |
0.0002 |
| 655 |
WHITE BLOOD CELL COUNT INCREASED |
8 |
0.0002 |
| 656 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 657 |
ASTHENIA |
78 |
0.0002 |
| 658 |
HYPOAESTHESIA |
31 |
0.0002 |
| 659 |
HERNIA |
4 |
0.0002 |
| 660 |
EAR PAIN |
4 |
0.0002 |
| 661 |
PRURITUS |
79 |
0.0002 |
| 662 |
NAUSEA |
162 |
0.0002 |
| 663 |
ARTHRALGIA |
85 |
0.0002 |
| 664 |
DRUG ABUSE |
17 |
0.0002 |
| 665 |
LUNG DISORDER |
10 |
0.0002 |
| 666 |
GAIT DISTURBANCE |
39 |
0.0002 |
| 667 |
ENCEPHALOPATHY |
5 |
0.0002 |
| 668 |
ANGIOEDEMA |
9 |
0.0002 |
| 669 |
KNEE OPERATION |
2 |
0.0002 |
| 670 |
BODY TEMPERATURE DECREASED |
2 |
0.0002 |
| 671 |
MUSCULAR WEAKNESS |
23 |
0.0002 |
| 672 |
DISABILITY |
4 |
0.0002 |
| 673 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
8 |
0.0002 |
| 674 |
CONSTIPATION |
44 |
0.0002 |
| 675 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 676 |
HYPERKALAEMIA |
7 |
0.0002 |
| 677 |
GASTROOESOPHAGEAL REFLUX DISEASE |
16 |
0.0002 |
| 678 |
FULL BLOOD COUNT DECREASED |
4 |
0.0002 |
| 679 |
TINNITUS |
9 |
0.0002 |
| 680 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 681 |
EYE PAIN |
11 |
0.0002 |
| 682 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 683 |
THYROID DISORDER |
3 |
0.0002 |
| 684 |
OROPHARYNGEAL PAIN |
18 |
0.0002 |
| 685 |
MUSCULOSKELETAL STIFFNESS |
17 |
0.0002 |
| 686 |
FLATULENCE |
11 |
0.0002 |
| 687 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 688 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 689 |
RESPIRATORY TRACT INFECTION |
5 |
0.0002 |
| 690 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 691 |
ANHEDONIA |
5 |
0.0002 |
| 692 |
GASTRITIS |
5 |
0.0002 |
| 693 |
MOUTH ULCERATION |
4 |
0.0002 |
| 694 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 695 |
CHEST PAIN |
35 |
0.0002 |
| 696 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 697 |
RETCHING |
4 |
0.0002 |
| 698 |
CARDIAC FAILURE |
15 |
0.0002 |
| 699 |
BREAST CANCER METASTATIC |
2 |
0.0002 |
| 700 |
PRODUCT USE IN UNAPPROVED INDICATION |
46 |
0.0002 |
| 701 |
PNEUMONIA |
60 |
0.0002 |
| 702 |
OFF LABEL USE |
162 |
0.0002 |
| 703 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 704 |
BACK DISORDER |
3 |
0.0002 |
| 705 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 706 |
DENTAL CARIES |
2 |
0.0002 |
| 707 |
DIZZINESS |
90 |
0.0002 |
| 708 |
FUNGAL INFECTION |
6 |
0.0002 |
| 709 |
FEELING COLD |
5 |
0.0002 |
| 710 |
WEIGHT INCREASED |
40 |
0.0002 |
| 711 |
ARTHRITIS |
14 |
0.0002 |
| 712 |
FISTULA |
2 |
0.0002 |
| 713 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 714 |
HEMIPARESIS |
3 |
0.0002 |
| 715 |
DYSPNOEA |
100 |
0.0002 |
| 716 |
MYALGIA |
30 |
0.0002 |
| 717 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 718 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 719 |
WHITE BLOOD CELL COUNT DECREASED |
19 |
0.0002 |
| 720 |
MICTURITION URGENCY |
2 |
0.0002 |
| 721 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 722 |
EPISTAXIS |
13 |
0.0002 |
| 723 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 724 |
LOCAL SWELLING |
3 |
0.0002 |
| 725 |
RASH MACULAR |
6 |
0.0002 |
| 726 |
HEART RATE DECREASED |
6 |
0.0002 |
| 727 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0002 |
| 728 |
DEPRESSED MOOD |
9 |
0.0002 |
| 729 |
COLD SWEAT |
3 |
0.0002 |
| 730 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 731 |
DEEP VEIN THROMBOSIS |
11 |
0.0002 |
| 732 |
BLOOD CREATININE INCREASED |
11 |
0.0002 |
| 733 |
GALLBLADDER DISORDER |
3 |
0.0002 |
| 734 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 735 |
COUGH |
47 |
0.0002 |
| 736 |
MUSCLE RIGIDITY |
2 |
0.0002 |
| 737 |
RENAL IMPAIRMENT |
14 |
0.0002 |
| 738 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 739 |
LOCALISED INFECTION |
4 |
0.0002 |
| 740 |
PELVIC PAIN |
3 |
0.0002 |
| 741 |
RESTLESS LEGS SYNDROME |
3 |
0.0002 |
| 742 |
NEURALGIA |
4 |
0.0002 |
| 743 |
AGITATION |
12 |
0.0002 |
| 744 |
HAEMATOCHEZIA |
9 |
0.0002 |
| 745 |
PAIN |
100 |
0.0002 |
| 746 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 747 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 748 |
BALANCE DISORDER |
14 |
0.0002 |
| 749 |
MEDICATION ERROR |
9 |
0.0002 |
| 750 |
OSTEONECROSIS OF JAW |
4 |
0.0002 |
| 751 |
HYPERSENSITIVITY |
30 |
0.0002 |
| 752 |
THROMBOSIS |
13 |
0.0002 |
| 753 |
VISUAL IMPAIRMENT |
20 |
0.0002 |
| 754 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 755 |
MEMORY IMPAIRMENT |
22 |
0.0002 |
| 756 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 757 |
LEUKOPENIA |
8 |
0.0002 |
| 758 |
PRODUCT DOSE OMISSION ISSUE |
47 |
0.0002 |
| 759 |
HALLUCINATION |
12 |
0.0002 |
| 760 |
SOMNOLENCE |
32 |
0.0002 |
| 761 |
INFECTION |
23 |
0.0002 |
| 762 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
| 763 |
CYSTITIS |
5 |
0.0002 |
| 764 |
HERPES ZOSTER |
9 |
0.0002 |
| 765 |
INJURY |
11 |
0.0002 |
| 766 |
LETHARGY |
9 |
0.0002 |
| 767 |
DRUG PRESCRIBING ERROR |
3 |
0.0002 |
| 768 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 769 |
GASTROINTESTINAL HAEMORRHAGE |
13 |
0.0002 |
| 770 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 771 |
ERUCTATION |
3 |
0.0002 |
| 772 |
SWELLING FACE |
10 |
0.0002 |
| 773 |
NODULE |
2 |
0.0002 |
| 774 |
KIDNEY INFECTION |
3 |
0.0002 |
| 775 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 776 |
NEPHROLITHIASIS |
7 |
0.0002 |
| 777 |
OSTEONECROSIS |
5 |
0.0002 |
| 778 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 779 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 780 |
DERMATITIS ATOPIC |
8 |
0.0002 |
| 781 |
SINUS DISORDER |
3 |
0.0002 |
| 782 |
CATARACT |
9 |
0.0002 |
| 783 |
LIP SWELLING |
5 |
0.0001 |
| 784 |
HAIR TEXTURE ABNORMAL |
2 |
0.0001 |
| 785 |
JAUNDICE |
4 |
0.0001 |
| 786 |
HEADACHE |
93 |
0.0001 |
| 787 |
DYSGEUSIA |
11 |
0.0001 |
| 788 |
ANXIETY |
42 |
0.0001 |
| 789 |
LIMB INJURY |
4 |
0.0001 |
| 790 |
FALL |
49 |
0.0001 |
| 791 |
NEUTROPENIA |
20 |
0.0001 |
| 792 |
PRODUCTIVE COUGH |
7 |
0.0001 |
| 793 |
CHEST DISCOMFORT |
15 |
0.0001 |
| 794 |
NASOPHARYNGITIS |
27 |
0.0001 |
| 795 |
BACK PAIN |
34 |
0.0001 |
| 796 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 797 |
BLOOD GLUCOSE DECREASED |
7 |
0.0001 |
| 798 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 799 |
CHILLS |
17 |
0.0001 |
| 800 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 801 |
ANAPHYLACTIC REACTION |
8 |
0.0001 |
| 802 |
DIABETES MELLITUS |
11 |
0.0001 |
| 803 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 804 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 805 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 806 |
INTERNATIONAL NORMALISED RATIO INCREASED |
4 |
0.0001 |
| 807 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 808 |
RECTAL HAEMORRHAGE |
6 |
0.0001 |
| 809 |
SKIN CANCER |
3 |
0.0001 |
| 810 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 811 |
HYPOKINESIA |
2 |
0.0001 |
| 812 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0001 |
| 813 |
PULMONARY EMBOLISM |
13 |
0.0001 |
| 814 |
BONE PAIN |
8 |
0.0001 |
| 815 |
SURGERY |
8 |
0.0001 |
| 816 |
MELAENA |
3 |
0.0001 |
| 817 |
MUSCLE SPASMS |
25 |
0.0001 |
| 818 |
BLOOD PRESSURE DECREASED |
9 |
0.0001 |
| 819 |
INSOMNIA |
36 |
0.0001 |
| 820 |
BRONCHITIS |
10 |
0.0001 |
| 821 |
TACHYCARDIA |
12 |
0.0001 |
| 822 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 823 |
WHEEZING |
8 |
0.0001 |
| 824 |
PULMONARY OEDEMA |
6 |
0.0001 |
| 825 |
THERAPEUTIC RESPONSE UNEXPECTED |
6 |
0.0001 |
| 826 |
CHROMATURIA |
3 |
0.0001 |
| 827 |
ASTHMA |
15 |
0.0001 |
| 828 |
HOT FLUSH |
10 |
0.0001 |
| 829 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 830 |
LACRIMATION INCREASED |
4 |
0.0001 |
| 831 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 832 |
VERTIGO |
8 |
0.0001 |
| 833 |
SHOCK |
3 |
0.0001 |
| 834 |
MALAISE |
57 |
0.0001 |
| 835 |
DISTURBANCE IN ATTENTION |
7 |
0.0001 |
| 836 |
RASH PRURITIC |
7 |
0.0001 |
| 837 |
DELUSION |
2 |
0.0001 |
| 838 |
LUNG INFECTION |
2 |
0.0001 |
| 839 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 840 |
PALPITATIONS |
15 |
0.0001 |
| 841 |
PRODUCT USE ISSUE |
24 |
0.0001 |
| 842 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 843 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
6 |
0.0001 |
| 844 |
CARDIAC FAILURE CONGESTIVE |
10 |
0.0001 |
| 845 |
HYPOGLYCAEMIA |
6 |
0.0001 |
| 846 |
PRESYNCOPE |
3 |
0.0001 |
| 847 |
RHEUMATOID ARTHRITIS |
14 |
0.0001 |
| 848 |
ATRIAL FIBRILLATION |
12 |
0.0001 |
| 849 |
AMNESIA |
8 |
0.0001 |
| 850 |
CHOLELITHIASIS |
4 |
0.0001 |
| 851 |
METASTASES TO BONE |
2 |
0.0001 |
| 852 |
MULTIPLE FRACTURES |
2 |
0.0001 |
| 853 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 854 |
TREATMENT FAILURE |
10 |
0.0001 |
| 855 |
VISUAL ACUITY REDUCED |
4 |
0.0001 |
| 856 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 857 |
AGEUSIA |
3 |
0.0001 |
| 858 |
SUICIDAL IDEATION |
11 |
0.0001 |
| 859 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 860 |
SYNCOPE |
12 |
0.0001 |
| 861 |
URTICARIA |
20 |
0.0001 |
| 862 |
ACNE |
9 |
0.0001 |
| 863 |
FLUID RETENTION |
6 |
0.0001 |
| 864 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 865 |
INFLUENZA |
13 |
0.0001 |
| 866 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 867 |
ILLNESS |
12 |
0.0001 |
| 868 |
HAEMATOMA |
3 |
0.0001 |
| 869 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 870 |
VAGINAL HAEMORRHAGE |
5 |
0.0001 |
| 871 |
DEAFNESS |
3 |
0.0001 |
| 872 |
TREMOR |
19 |
0.0001 |
| 873 |
PARAESTHESIA |
18 |
0.0001 |
| 874 |
DEPRESSION |
26 |
0.0001 |
| 875 |
HYPOXIA |
4 |
0.0001 |
| 876 |
PANCREATITIS |
6 |
0.0001 |
| 877 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 878 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 879 |
THERAPY INTERRUPTED |
8 |
0.0001 |
| 880 |
BONE DISORDER |
2 |
0.0001 |
| 881 |
HYPERHIDROSIS |
14 |
0.0001 |
| 882 |
RHINORRHOEA |
7 |
0.0001 |
| 883 |
COVID-19 |
19 |
0.0001 |
| 884 |
PROCEDURAL PAIN |
3 |
0.0001 |
| 885 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 886 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 887 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 888 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 889 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 890 |
FRACTURE |
2 |
0.0001 |
| 891 |
MULTIPLE SCLEROSIS |
5 |
0.0001 |
| 892 |
FEELING ABNORMAL |
25 |
0.0001 |
| 893 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 894 |
CHOLESTASIS |
2 |
0.0001 |
| 895 |
DYSSTASIA |
3 |
0.0001 |
| 896 |
DYSPEPSIA |
10 |
0.0001 |
| 897 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 898 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 899 |
BURNING SENSATION |
7 |
0.0001 |
| 900 |
PREMATURE BABY |
3 |
0.0001 |
| 901 |
APHASIA |
3 |
0.0001 |
| 902 |
SKIN BURNING SENSATION |
7 |
0.0001 |
| 903 |
INFLUENZA LIKE ILLNESS |
8 |
0.0001 |
| 904 |
FEMUR FRACTURE |
3 |
0.0001 |
| 905 |
NERVOUSNESS |
5 |
0.0001 |
| 906 |
BLOOD GLUCOSE INCREASED |
18 |
0.0001 |
| 907 |
MOOD SWINGS |
3 |
0.0001 |
| 908 |
EATING DISORDER |
2 |
0.0001 |
| 909 |
LOSS OF CONSCIOUSNESS |
12 |
0.0001 |
| 910 |
HYPOACUSIS |
4 |
0.0001 |
| 911 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 912 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 913 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 914 |
VIRAL INFECTION |
3 |
0.0001 |
| 915 |
MATERNAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 916 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 917 |
OVERDOSE |
19 |
0.0001 |
| 918 |
INJECTION SITE BRUISING |
7 |
0.0001 |
| 919 |
DRUG INEFFECTIVE |
115 |
0.0001 |
| 920 |
DRUG DEPENDENCE |
14 |
0.0001 |
| 921 |
NASAL CONGESTION |
5 |
0.0001 |
| 922 |
INJECTION SITE PAIN |
26 |
0.0001 |
| 923 |
ARRHYTHMIA |
4 |
0.0001 |
| 924 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 925 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 926 |
MIGRAINE |
8 |
0.0001 |
| 927 |
MYELOSUPPRESSION |
3 |
0.0001 |
| 928 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 929 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 930 |
UNDERDOSE |
6 |
0.0001 |
| 931 |
HEART RATE INCREASED |
8 |
0.0001 |
| 932 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 933 |
HAEMATEMESIS |
2 |
0.0001 |
| 934 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
2 |
0.0001 |
| 935 |
HAEMORRHAGE |
8 |
0.0001 |
| 936 |
BRADYCARDIA |
4 |
0.0001 |
| 937 |
BREAST CANCER FEMALE |
2 |
0.0001 |
| 938 |
CARDIAC DISORDER |
7 |
0.0001 |
| 939 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 940 |
TREATMENT NONCOMPLIANCE |
4 |
0.0001 |
| 941 |
VISION BLURRED |
10 |
0.0001 |
| 942 |
DIVERTICULITIS |
2 |
0.0001 |
| 943 |
DEMENTIA |
2 |
0.0001 |
| 944 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 945 |
ANGINA PECTORIS |
2 |
0.0001 |
| 946 |
HYPERSOMNIA |
2 |
0.0001 |
| 947 |
SEIZURE |
8 |
0.0001 |
| 948 |
MENTAL DISORDER |
3 |
0.0001 |
| 949 |
NEEDLE ISSUE |
2 |
0.0001 |
| 950 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 951 |
THROAT IRRITATION |
3 |
0.0001 |
| 952 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
| 953 |
FEELING HOT |
4 |
0.0001 |
| 954 |
HOSPITALISATION |
10 |
0.0001 |
| 955 |
RENAL DISORDER |
3 |
0.0001 |
| 956 |
COLORECTAL CANCER |
3 |
0.0001 |
| 957 |
DEATH |
53 |
0.0001 |
| 958 |
EYE DISORDER |
2 |
0.0001 |
| 959 |
CARDIAC ARREST |
5 |
0.0001 |
| 960 |
INJECTION SITE PRURITUS |
4 |
0.0001 |
| 961 |
FLUSHING |
6 |
0.0001 |
| 962 |
MULTIPLE SCLEROSIS RELAPSE |
4 |
0.0001 |
| 963 |
SPEECH DISORDER |
3 |
0.0001 |
| 964 |
DRUG INTERACTION |
9 |
0.0001 |
| 965 |
DEVICE ISSUE |
5 |
0.0001 |
| 966 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 967 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 968 |
INJECTION SITE MASS |
2 |
0.0001 |
| 969 |
EYE SWELLING |
2 |
0.0001 |
| 970 |
DYSARTHRIA |
2 |
0.0001 |
| 971 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 972 |
INCORRECT DOSE ADMINISTERED |
12 |
0.0001 |
| 973 |
CONVULSION |
3 |
0.0001 |
| 974 |
EYE IRRITATION |
3 |
0.0001 |
| 975 |
INJECTION SITE HAEMORRHAGE |
4 |
0.0001 |
| 976 |
IRRITABILITY |
3 |
0.0000 |
| 977 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 978 |
DYSKINESIA |
2 |
0.0000 |
| 979 |
MYOCARDIAL INFARCTION |
8 |
0.0000 |
| 980 |
COMA |
2 |
0.0000 |
| 981 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
8 |
0.0000 |
| 982 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 983 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 984 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 985 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 986 |
DRUG DOSE OMISSION |
5 |
0.0000 |
| 987 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 988 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 989 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 990 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 991 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 992 |
BREAST CANCER |
2 |
0.0000 |
| 993 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 994 |
NO ADVERSE EVENT |
3 |
0.0000 |